RO7284755

DB17527InvestigationalProtein Based Therapies

RO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein. RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor...

Mechanism: Pharmacologically active on Programmed cell death protein 1
Curator reviewed
Also known as: RO 7284755 · RO-7284755
Code names: RG-6279

Resolves to

Compound

UNIIXPV3BT6FPY

Targets

Q15116PDCD1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with RO7284755, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account